WPRIM Management System> DCMS> Blood Research> 2015> 50> 2

Volume: 50 Issue: 2

1. Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensus. Page:69—70
2. Mesenchymal niche: the sensor and effector of leukemogenesis. Page:67—68
3. New approaches for cholestasis in hemoglobinopathies. Page:118—121
4. Pseudo gray platelet syndrome: the first case report in Korea. Page:117—118
5. Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation. Page:114—117
6. Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent. Page:113—114
7. Stability of eosin-5'-maleimide dye used in flow cytometric analysis for red cell membrane disorders. Page:109—112
8. Human coagulation factor VIII domain-specific recombinant polypeptide expression. Page:103—108
9. Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma. Page:97—102
10. Bortezomib inhibits the survival and proliferation of bone marrow stromal cells. Page:87—96
11. Down-regulation of the autophagy gene, ATG7, protects bone marrow-derived mesenchymal stem cells from stressful conditions. Page:80—86
12. Apoptosis: role in myeloid cell development. Page:73—79
13. Intraleukocytic hemozoin pigments in complicated Plasmodium falciparum cerebral malaria. Page:72—72
14. Gelatinous transformation of the bone marrow in hepatocellular carcinoma. Page:71—71